Suppr超能文献

脂多糖-胺纳米聚合物囊泡负载骨形态发生蛋白2质粒介导的骨髓间充质干细胞基因转染研究

[Study on gene transfection in bone marrow mesenchymal stem cells mediated by plasmid of bone morphogenetic protein 2 loaded lipopolysaccharide-amine nanopolymersomes].

作者信息

Guan Yun, Wang Qinmei, Cheng Ying, Teng Wei, Huang Hongzhang

机构信息

Department of Prosthodontics, guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, Guangzhou Guangdon, P.R. China.

出版信息

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Oct;28(10):1292-7.

Abstract

OBJECTIVE

To evaluate the combination of lipopolysaccharide-amine nanopolymersomes (LNPs), as a gene vector, with target gene and the transfection in bone marrow mesenchymal stem cells (BMSCs) so as to provide a preliminary experiment basis for combination treatment of bone defect with gene therapy mediated by LNPs and stem cells.

METHODS

Plasmid of bone morphogenetic protein 2 (pBMP-2)-loaded LNPs (pLNPs) were prepared. The binding ability of pLNPs to pBMP-2 was evaluated by a gel retardation experiment with different ratios of nitrogen to phosphorus elements (N/P). The morphology ofpLNPs (N/P = 60) was observed under transmission electron microscope (TEM) and atomic force microscope (AFM). The size and Zeta potential were measured by dynamic light scattering (DLS). The resistance of pLNPs against DNase I degradation over time was explored. The viability of BMSCs, transfection efficiency, and expression of target protein were investigated after transfection by pLNPs in vitro.

RESULTS

At N/P ≥ 1.5, pLNPs could completely retard pBMP-2; at N/P of 60, pLNPs was uniform vesicular shape under AFM; TEM observation demonstrated that pLNPs were spherical nano-vesicles with the diameter of (72.07 ± 11.03) nm, DLS observation showed that the size of pLNPs was (123 ± 6) nm and Zeta potential was 20 mV; pLNPs could completely resist DNase I degradation within 4 hours, and such protection capacity to pBMP-2 decreased slightly at 6 hours. The cell survival rate first increased and then decreased with the increase of N/P, and reached the maximum value at N/P of 45; the cytotoxicity was in grade I at N/P ≤ 90, which meant no toxicity for in vivo experiment. While the transfection efficiency of pLNPs increased with the increase of N/P, and reached the maximum value at N/P of 60. So it is comprehensively determined that the best N/P was 60. At 4 days, transfected BMSCs expressed BMP-2 continuously at a relatively high level at N/P of 60.

CONCLUSION

LNPs can compress pBMP-2 effectively to form the nanovesicles complex, which protects the target gene against enzymolysis. LNPs has higher transfection efficiency and produces more amount of protein than polyethylenimine 25k and Lipofectamine 2000.

摘要

目的

评估脂多糖-胺纳米聚合物囊泡(LNPs)作为基因载体与靶基因的组合以及在骨髓间充质干细胞(BMSCs)中的转染情况,为LNPs介导的基因治疗与干细胞联合治疗骨缺损提供初步实验依据。

方法

制备负载骨形态发生蛋白2(pBMP-2)的LNPs(pLNPs)。通过不同氮磷元素比(N/P)的凝胶阻滞实验评估pLNPs与pBMP-2的结合能力。在透射电子显微镜(TEM)和原子力显微镜(AFM)下观察pLNPs(N/P = 60)的形态。通过动态光散射(DLS)测量其大小和Zeta电位。探究pLNPs随时间对DNase I降解的抗性。体外转染pLNPs后,研究BMSCs的活力、转染效率及靶蛋白表达。

结果

当N/P≥1.5时,pLNPs可完全阻滞pBMP-2;N/P为60时,AFM下pLNPs呈均匀囊泡状;TEM观察显示pLNPs为直径(72.07±11.03)nm的球形纳米囊泡,DLS观察显示pLNPs大小为(123±6)nm,Zeta电位为20 mV;pLNPs在4小时内可完全抵抗DNase I降解,6小时时对pBMP-2的保护能力略有下降。细胞存活率随N/P增加先升高后降低,在N/P为45时达到最大值;N/P≤90时细胞毒性为I级,意味着对体内实验无毒性。而pLNPs的转染效率随N/P增加而升高,在N/P为60时达到最大值。综合确定最佳N/P为60。在4天时,N/P为60时转染的BMSCs持续高水平表达BMP-2。

结论

LNPs可有效压缩pBMP-2形成纳米囊泡复合物,保护靶基因免受酶解。LNPs比聚乙烯亚胺25k和脂质体2000具有更高的转染效率且产生更多的蛋白。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验